- Who we are
- Wellness & Prevention
- Warrior
- Uncategorized
- Twitter Chats
- Triple Negative Breast Cancer
- Toolkit
- Tiger Talk Blog Series
- The Fearless Warrior Project
- Survivorship
- Stories
- Spirituality
- SABCS 2023
- SABCS
- Reflections
- Publications
- Programs
- Press Release
- Pledge Partner
- Nutrition
- Newsletter
- My Life
- MY LIFE
- Mindful Moments
- Metastatic Breast Cancer
- Metastatic Breast Cancer
- Love Your Bones
- Living with MBC
- Healthy Lifestyle
- Education
- Clincial Trials
- CLEART
- children
- Breast Cancer Toolkit
- Breast Cancer 101
- bone health
- Blog
- ANGEL Advocate
- All
Triple Bite: Badass, Passionate, Stubborn (3 of 5)
Received from Sarah Kelly, Co-founder of SaltyGirlBeauty, www.saltygirlbeauty.com In 2015, Sarah was diagnosed with Stage 3 Triple Negative Breast Cancer, at 36 years old and 32 weeks pregnant. When something […]
TNBC Clinical News (2 of 5)
Immunomedics’ sacituzumab govitecan drug shrinks tumors of metastatic Triple Negative Breast Cancer Patients IMMU-132-01 Phase 1/2 clinical trial using Immunomedics’ sacituzumab govitecan drug has revealed that this drug increases survival […]
Triple Bite: Maimah Karmo – CEO Survivor, Advocate and Badass (1 of 5)
As a Triple Negative Breast Cancer Survivor, I’m thankful for efforts that highlight TNBC. When I was first diagnosed 13 years ago, someone told me it was the good type […]
My Diagnosis & Discovering my Jenfluence
By: Jen Hoverstad Before March of 2018, I led a seemingly vanilla life in Raleigh, North Carolina – the same city where I was born. I’m 34 and married my […]
New advances in breast cancer research and treatment
Tigerlily is excited to share new advances in breast cancer research and treatment that can benefit our patient community. We hope these updates will help keep you on top of […]
Update on New Advances in Breast Cancer Research
Tigerlily is excited to share new advances in breast cancer research that can benefit our patient community. We hope these updates will help keep you on top of the latest […]